Browse drugs

…ice on purchasing a semi-bespoke mandibular advancement device (MAD). SMS follow-up at 8 and 20 weeks offered options to confirm MA…

…e moderate to severe OSA (AHI >15). Three patients have started CPAP therapy and four have been advised to make lifestyle changes.Co…

…ignificant proportion of patients with OSA struggle to tolerate CPAP. Maxillo-mandibular advancement (MMA) represents an effective s…

…lent within South-Asian communities. There was a consensus that inhalers were not used in public due to stigmas attached to asthma withi…

…elays in appropriate diagnosis and management, and accompanying oral corticosteroid associated comorbidities.…

…les and the tube not under ‘real-time’ ultrasound guidance, and anaesthetic is injected at a depth approximating that of the external pleur…

…tently low trajectory were evident for plasma concentrations of CXCL10 (OR per quintile 1.26 [1.04–1.52]), IL6 (OR per log 2 rise 1.43…

…burden (median 5 exacerbations [IQR 4, 8] in previous year) and mOCS use (49.9% of patients). Clinical remission was achieved in 25.…

… & up to 40% of patients receive repeated oral corticosteroids (OCS). Without objective markers, prescribing decisions rely on symp…

…ted with anticoagulation pre-admission. Treatment: 82% received antibiotics, 57% received corticosteroids, 19% received diuretics, and 3% r…

…sion or response to treatment are not available. In addition to Plasminogen Activator Inhibitor 1 (PAI-1) and Soluble Urokinase Plasminogen Activator Receptor (s…

…les associated with lung cancer that could be incorporated into Inflammacheck® in the future to improve performance.Reference Fox L, D’Cruz L…